Agios Pharmaceuticals, Inc.
AGIO
$29.20
-$1.03-3.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -108.04M | -103.43M | -112.02M | -89.29M | -96.52M |
| Total Depreciation and Amortization | 1.27M | 1.37M | 1.26M | 1.28M | 1.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.15M | 14.14M | 25.35M | 13.03M | 8.25M |
| Change in Net Operating Assets | -4.59M | -231.00K | 8.28M | -36.51M | -46.26M |
| Cash from Operations | -96.21M | -88.15M | -77.12M | -111.49M | -133.17M |
| Capital Expenditure | -1.12M | -1.56M | -875.00K | -766.00K | -967.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | 0.00 |
| Other Investing Activities | 91.20M | 97.11M | 79.84M | 113.35M | -48.19M |
| Cash from Investing | 90.08M | 95.56M | 78.97M | 112.59M | -49.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.56M | 4.44M | 65.00K | 1.62M | 4.84M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.56M | 4.44M | 65.00K | 1.62M | 4.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.58M | 11.84M | 1.91M | 2.72M | -177.48M |